K Number
K012208
Date Cleared
2001-09-07

(53 days)

Product Code
Regulation Number
866.5870
Panel
IM
Reference & Predicate Devices
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Access® Thyroglobulin Antibody (TgAb) assay is a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of thyroglobulin antibody levels in human serum and plasma using the Access® Immunoassay Systems. The measurement of thyroid autoantibodies may aid in the diagnosis of certain thyroid disorders, such as Hashimoto's disease, nontoxic goiter, and Graves' disease.

Device Description

The Access Thyroglobulin Antibody reagents, Thyroglobulin Antibody calibrators, and the Access Immunoassay Analyzer comprise the Access Immunoassay System for the quantitative determination of thyroglobulin antibody in human serum and plasma.

AI/ML Overview

Here's a breakdown of the acceptance criteria and study information for the Access® Thyroglobulin Antibody assay, based on the provided text:

Acceptance Criteria and Reported Device Performance

Acceptance Criteria CategoryReported Device Performance
Analytical SpecificityNo significant interference from potential sample contaminants (total protein, bilirubin, hemoglobin, and triglycerides). Only one discrepancy found between interpretations positive and negative when compared to the predicate device for autoimmune disease samples.
Analytical SensitivityLowest detectable level: 1.5 IU/mL (at 95% confidence). An analytical sensitivity of 2.2 IU/mL will be used in labeling.
Dilution RecoveryOverall mean recovery: 95%. Individual mean sample recoveries: 90% to 100%.
PrecisionWithin-run imprecision: 3.99 to 5.04 % CV
Between-run imprecision: 1.95 to 4.66 % CV
Total imprecision: 4.47 to 6.74 % CV (at levels between 34.1 and 1,693 IU/ml)
Hook EffectNo hook effect demonstrated up to 350,000 IU/ml.
Relative Sensitivity vs. Predicate79.0%
Relative Specificity vs. Predicate87.6%
Method Comparison (Correlation with Predicate)Correlation coefficient (r) = 0.816
Slope (y) = 0.957
Intercept = -5.886
Reagent Stability56 days after opening.
Calibration Curve Stability56 days.

Study Information

  1. Sample size used for the test set and the data provenance:
    • Test Set Sample Size:
      • Relative Sensitivity and Specificity: 296 serum samples (99 with Graves' disease, 97 with Hashimoto's disease, and 100 normals).
      • Method Comparison: 276 samples (values ranging from approximately

§ 866.5870 Thyroid autoantibody immunological test system.

(a)
Identification. A thyroid autoantibody immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the thyroid autoantibodies (antibodies produced against the body's own tissues). Measurement of thyroid autoantibodies may aid in the diagnosis of certain thyroid disorders, such as Hashimoto's disease (chronic lymphocytic thyroiditis), nontoxic goiter (enlargement of thyroid gland), Grave's disease (enlargement of the thyroid gland with protrusion of the eyeballs), and cancer of the thyroid.(b)
Classification. Class II (performance standards).